Overnight Digest – Stocks to look out for on June 1
DSIJ Intelligence / 31 May 2017
The stocks which are expected to witness significant movement on June 1 are Unitech, Sun Pharma, Indian Oil & BPCL, HUL, Aurbindo Pharma.
The stocks which are expected to witness significant movement on June 1 are Unitech, Sun Pharma, Indian Oil & BPCL, HUL, Aurbindo Pharma.
Unitech Ltd. – For quarter ended March 31, 2017, the company's net loss has been reduced to Rs 291.25 crore as compared to the net loss of Rs 483.54 crore a year ago. The share price of the company will remain in the limelight on Thursday.
Sun Pharma – The company has recalled 13,000 bottles of chewable Cetirizine for children in the US. The share price will remain in focus on Thursday.
Indian Oil & BPCL – IOC and BPCL are in talks to buy about 49 per cent stake in Russian’s Vankor cluster oilfields. The share price of these companies will be watched on June 1.
Hindustan Unilever Limited- HUL reported about 6.2 per cent increase in the net profit compared to the same quarter previous year on Wednesday. The share price of the company will remain in focus on Thursday.
Aurobindo Pharma- The company has received approval from the US Food and Drug Administration to manufacture Atomoxetine capsules which are used for the treatment of attention-deficit hyperactivity disorder. The share price of the company will remain in the limelight on Thursday.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.